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Abstract
Background: Hypoxia Inducible Factor (HIF) regulates a cascade of transcriptional events in response to decreased
oxygenation, acting from the cellular to the physiological level. This response is evolutionarily conserved, allowing
the use of zebrafish (Danio rerio) as a model for studying the hypoxic response. Activation of the hypoxic response
can be achieved in zebrafish by homozygous null mutation of the von Hippel-Lindau (vhl) tumour suppressor gene.
Previous work from our lab has focused on the phenotypic characterisation of this mutant, establishing the links
between vhl mutation, the hypoxic response and cancer. To further develop fish as a model for studying hypoxic
signalling, we examine the transcriptional profile of the vhl mutant with respect to Hif-1α. As our approach uses
embryos consisting of many cell types, it has the potential to uncover additional HIF regulated genes that have
escaped detection in analogous mammalian cell culture studies.
Results: We performed high-density oligonucleotide microarray analysis of the gene expression changes in von
Hippel-Lindau mutant zebrafish, which identified up-regulation of well-known hypoxia response genes and
down-regulation of genes primarily involved in lipid processing. To identify the dependency of these transcriptional
changes on HIF, we undertook Chromatin Immunoprecipitation linked next generation sequencing (ChIP-seq) for the
transcription factor Hypoxia Inducible Factor 1α (HIF-1α). We identified HIF-1α binding sites across the genome, with
binding sites showing enrichment for an RCGTG motif, showing conservation with the mammalian hypoxia response
element.
Conclusions: Transcriptome analysis of vhl mutant embryos detected activation of key hypoxia response genes seen in
human cell models of hypoxia, but also suppression of many genes primarily involved in lipid processing. ChIP-seq
analysis of Hif-1α binding sites unveiled an unprecedented number of loci, with a high proportion containing a canonical
hypoxia response element. Whether these sites are functional remains unknown, nevertheless their frequent location near
transcriptional start sites suggests functionality, and will allow for investigation into the potential hypoxic regulation of
genes in their vicinity. We expect that our data will be an excellent starting point for analysis of both fish and mammalian
gene regulation by HIF.
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Background
Most multicellular life is heavily dependent on oxygen for
survival. Multicellular organisms inhabit environments that
have changing oxygen availability, and show conserved
mechanisms to cope with extremes of oxygen availability
which can occur both in their environment and within
their tissues [1]. This high level of conservation means that
non-mammalian model organisms can be employed to
study the regulation of the hypoxic response. Furthermore,
studies in fish might also provide the basis to understand
how such responses are modified in aquatic environments,
where oxygen availability can widely vary [2].
Hypoxia Inducible Factor (HIF) is central to the re-
sponse to the lack of oxygen in the environment [3]. In
order to maintain homeostasis; cells, tissues and organ-
isms adapt to first cope with the lack of oxygen and then
act to redress the underlying cause [3]. In order to reduce
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oxygen consumption, the HIF transcription factor orches-
trates a metabolic shift from aerobic metabolism to gly-
colysis. It leads to: 1) Alteration in the composition of the
electron transport chain [4]. 2) Induction of pyruvate
dehydrogenase kinase switching metabolism away from
oxidative phosphorylation [5, 6]. 3) Up-regulation of
glycolytic genes [7, 8]. 4) Regulation of mitochondrial
turnover [9, 10]. The HIF pathway also increases glu-
cose trafficking into the cell by up-regulation of the
glucose transporter GLUT1 [11]. To counteract hyp-
oxia, HIF stimulates erythrocyte production through
up-regulation of EPO and a host of iron absorption re-
lated genes [12–16], and by increasing angiogenesis
through increased production of angiogenic factors,
like VEGF [17–20]. More recently, HIF has been impli-
cated in lipid processing, mice carrying a hepatic knock-
out of Vhl develop severe hepatic steatosis with impaired
fatty acid oxidation, decreased lipogenic gene expression,
and increased lipid storage capacity [21]. Activation of the
HIF pathway is implicated in tumour development and
growth, as the interior of most solid tumours is hypoxic.
Furthermore loss-of-heterozygosity of VHL leads to acti-
vation of HIFs, which is essential for VHL-driven tumori-
genesis [22–24].
The HIF transcription factor is a basic-helix-loop-helix
heterodimer consisting of an αand β subunit [25, 26]. The
expression of HIF-α is regulated by the Prolyl-Hydroxylase
Domain containing enzymes (PHD 1–3), which act to hy-
droxylate HIF-α under conditions of plentiful oxygen, lead-
ing to its recognition by von Hippel Lindau (pVHL) and
subsequent proteosomal degradation [27–31]. Thus under
conditions of normoxia, HIF-α is continually degraded.
Under hypoxic conditions or, for instance, after mutation
of VHL, the breakdown of HIF-α is inhibited. This leads to
its translocation into the nucleus to bind HIF-β, creating
the HIF dimer. This dimer is then capable of binding to
Hypoxia Response Elements (HRE) within the genome
which leads to transcriptional activation of target genes
[12, 32]. HRE’s are characterised by a RCGTG binding
motif, functional motifs are often found in the promoters
of hypoxia response genes but have also been seen to act
distally [33]. Previous work from the Ratcliffe and Mole
labs have used the MCF-7 breast cancer cell line, stimu-
lated using the hydroxylase inhibitor dimethyloxalylgly-
cine (DMOG) or ≤1 % oxygen for 16 h in order activate
the HIF response. These screens identified binding sites
for both HIF-1α and HIF-2α binding sites using ChIP-
chip [34] and ChIP-seq [33]. Both studies identify the
canonical HRE, with Mole et al., finding 546 HIF-1α
binding sites (putatively linked to 394 loci, 20.8 % of
which are up-regulated FC ≥ 4, 15.6 % down-regulated)
and 143 HIF-2α binding sites (134 loci, 32.8 % up-
regulated FC ≥ 4, 1.5 % down-regulated). Similarly, the
Schödel study found 400 HIF-1α binding sites (356 loci)
and 425 HIF-2α binding sites (357 loci) [33]. Addition-
ally, Gene Set Enrichment Analysis found strong correl-
ation between HIF binding sites and up-regulation of
genes, whilst there was no correlation between down-
regulated genes [33]. Contrary to the situation humans,
in zebrafish, few functional HREs have been defined.
The HREs which likely control erythropoietin, igfbp1a
and period1b expression in zebrafish have been identi-
fied, showing an identical motif to human [35–37]. The
HREs for four Hif-2α specific genes, birc5a/b and
leg1a/b have been identified [38, 39]. Thus, in order to
further develop the zebrafish as a model for research
into hypoxic signalling, there is scope for systematic
identification HIF binding sites.
Heterozygous mutation of VHL in humans predis-
poses affected individuals to the development of highly
vascularised tumours and cysts upon loss of heterozy-
gosity of the remaining VHL allele, this is known as
VHL disease [40]. In order to study this disease further,
the vhl mutant zebrafish line was created. Homozygous
mutants display a systemic hypoxic response that
occurs once the remaining maternal vhl mRNA is
depleted [41]. The earliest activation of the Hif pathway
can be seen by 24 h post fertilisation (hpf ) with up-
regulation of phd3 (egln3), ndufa4 and ldha1a detect-
able by in situ hybridisation [42]. Activation of the
hypoxic response manifests itself in increased vegf
receptor-dependent increases in neovascularisation
[42]. In addition, vhl mutants exhibit strong increases
in both red and white blood cell lineages, reminiscent
of Chuvash polycythemia. This is a human disease
caused by particular VHL mutations [42, 43]. Zebrafish
vhl mutants display pronephric abnormalities from
soon after the nascent kidney becomes functional.,
Interestingly, the cells of the pronephros display a
phenotype reminiscent of the clear cell phenotype seen
in clear cell Renal Cell Carcinoma (ccRCC), a disease
caused by loss of heterozygosity of VHL, but do not de-
velop tumours or cysts [42, 44, 45]. We chose the vhl
mutant line as a model for hypoxia as we believed that
genetic inactivation of vhl offered a stronger and more
stable activation of the Hif pathway than pharmaco-
logical activation or physical hypoxia, whilst avoiding
complications due to developmental retardation and
other abnormalities resulting secondarily from severe
hypoxia.
Here we report analysis of the gene expression changes
in vhl mutant embryos, finding differential regulation of
both key hypoxia response genes and genes not commonly
associated with mutation of vhl. We report analysis of the
Hif-1α binding sites within both vhl mutant and wild-type
samples, finding a greater number binding sites than
expected from mammalian studies [39, 40], and identify a
HRE motif in zebrafish.
Greenald et al. BMC Genomics  (2015) 16:923 Page 2 of 17
Results
Identification of genes differentially expressed in vhl
mutant zebrafish
Vhl mutant zebrafish has been previously shown to
exhibit a systemic hypoxic response with increased levels
of Hif-1α seen in vhl deficient tumours [41, 42, 46]. Here
we perform one-colour microarray analysis using an
Agilent platform to determine the changes in gene
expression caused by homozygous mutation of vhl at
4dpf. We chose to perform experiments at 4dpf because
the phenotype of vhl mutants is clearly developed by
4dpf but embryos still appear healthy, without oedema.
Therefore, using this time point may reduce the number
of gene expression changes associated with secondary
complications when compared to a later stage of devel-
opment. For both wild-type and vhl mutant conditions,
three biological replicates were created, with each
replicate consisting of material from 30 embryos. Vhl
samples were compared against wild-type samples using
limma analysis for single channel microarray data
utilising background correction and quantile data
normalisation [47–50]. A p-value of ≤0.01 was used as a
cut-off for significance and entities with a fold-change of
greater or equal to two were considered to be differen-
tially regulated. This produced a probeset of 1409 differ-
entially regulated entities, of these, 1022 had unique
Unigene ID’s, which corresponded to 737 genes with
unique Unigene description. Of these genes, 295 were up-
regulated and 442 were down-regulated (Additional file 1).
The complete list of expressed entities can be found in
Additional file 2.
The transcriptional response to hypoxia has been well
studied in mammalian cells and zebrafish have been used
as a model to study this pathway [33, 41, 42, 46, 51, 52]. In
our microarray we detected significant up-regulation of an
array of hypoxia response genes in vhl mutants. We detect
increased expression of genes that regulate the HIF path-
way itself, such as Egl nine homolog 3 (C. elegans) (egln3
(aka phd3)) which our lab has utilised as a live hypoxia
reporter [46]. Similarly, we see an increase in classical hyp-
oxia response genes such as, the key regulator of angio-
genesis Vascular endothelial growth factor Ab (vegfab)
[53]. A number of glycolytic genes were also significantly
up-regulated; 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3 (pfkfb3) [8], and Lactate dehydrogenase
A4 (ldha) [7]. Additionally, a number of genes relating to
processing of the extracellular matrix were up-regulated,
including; Procollagen-lysine 1, 2-oxoglutarate 5-
dioxygenase 1a (plod1a) [54] and Procollagen-proline, 2-
oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha
polypeptide 2 (p4ha2) [55]. Interestingly, we see a large
number of down-regulated genes. Such transcriptional
repression is not commonly associated with activation of
the HIF response in cellular models [33].
These gene expression changes in vhl mutants
highlighted above were reflected in the results of Gene
Ontology (GO) Term based analysis performed using
Database for Annotation, Visualization and Integrated
Discovery (DAVID) [56, 57]. The complete entity lists of
differentially regulated genes in vhl mutants (found in
Additional file 1) were uploaded to DAVID using Unigene
ID as the identifier and analysed on the basis of the
Biological Processes that they are involved in. Enrichment
of biological processes for up-regulated transcripts found
key terms associated with the hypoxic response such as;
“oxygen transport”, “glycolysis” and “hemopoiesis”, strongly
implicating activation of the HIF-pathway [2, 3]. Down-
regulated transcripts were enriched in a number of
Biological Processes associated with lipid processing such
as; “lipid biosynthetic process” and “fatty acid metabolic
process”. The complete list of enriched biological processes
for both up- and down-regulated transcripts can be found
in Additional file 3.
In order to validate of our microarray results, quanti-
fication of fold-changes by quantitative polymerase
chain reaction (q-PCR) was performed using the Pfaffl
method [58] and the correlation between these and the
microarray fold changes was assessed using Spearman’s
Rho. q-PCR was performed for 24 up-regulated genes
with normalisation against the reference genes 18 s and
wnt5a, both of which have been used previously as
reference genes for quantification of mRNA in zebrafish
[59, 60]. Correlation was significant between the fold-
changes detected by microarray and by q-PCR analysis
regardless of which reference gene was used for the
qPCR analysis (18 s: ρ = 0.7496, p < 0.001, n = 24;
wnt5a: ρ = 0.7567, p < 0.001, n = 24), an observation
that is in line with results from other studies [61].
ChIP-qPCR experiments show specific enrichment for the
epo-HRE in vhl mutants
The HIF binding consensus sequence, the Hypoxia Re-
sponse Element, has been widely studied in mammalian
cells; from its initial identification due to its association
with transcriptional activation of erythropoietin, to exten-
sive ChIP-sequencing of cells exposed to hypoxic condi-
tions [12, 33]. In fish, a functional HRE that influences the
expression of erythropoietin has been identified, with the
consensus sequence being identical to that found in mam-
mals (ACGTGCTG) [35]. We tested several custom-
made/commercial Hif-1α antibodies for their suitability
for ChIP. The first step was to demonstrate that the Hif-
1α antibody was able to specifically bind to the epo-HRE.
This was achieved by performing ChIP followed by q-PCR
for the region surrounding the previously identified HRE
[35]. The DNA for this was isolated from a group of 2400
wild-type larvae pooled into a single sample and 2400 vhl
mutant larvae pooled into a separate sample, this DNA
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was later used for the ChIP-seq experiments. Enrichment
was measured using a variation on the Pfaffl method [58],
where the CT value for both the ChIP and the input con-
trol are calculated for the region of interest and addition-
ally for a distal control region. We would expect that in
vhl mutants, there would be greater enrichment for the
region directly over the HRE than for regions that are
both up- and down-stream to it, whereas the enrichment
would not be seen in wild-type ChIP material. Only one
antiserum gave a positive result (Fig. 1): a polyclonal fish-
specific Hif-1α antibody used previously to identify Hif-1α
in hypoxia-treated zebrafish [62] This serum also gives
good signals in western blots of larval zebrafish [46].
Therefore, this antiserum was used for the ChIP-seq
experiments.
Identification of Hif-1α binding sites in the zebrafish
genome
As few Hif-1α binding sites have been identified in zebra-
fish and ChIP-sequencing has emerged as an appropriate
technology for genome-wide DNA binding site analysis in
zebrafish, we decided to sequence the ChIP material
isolated from both wild-type and vhl mutants using one
biological replicate of 2400 embryos for each. ChIP mater-
ial was prepared for library submission using the Tru-Seq
low input library preparation kit, (despite the use of large
numbers of embryos only a relatively small amount of
ChIP material could be isolated) and then sequenced
using the Illumina platform. The sequencing data was
analysed using Model-based analysis of ChIP-Seq (MACS)
(version 1.4.2 20120305) which was able to call the
number of peaks enriched in the ChIP material for vhl
and wild-type with a p-value of ≤ 1x10−5 (corresponding
to a score of >50 in MACS). In total, there were 1280
peaks for wild-type and 5177 peaks for vhl with a p-value
of ≤10−5. Of 1280 peaks found in the wild-type sample,
157 peaks overlapped the 5177 peaks found in the vhl
sample, equating to 12.3 %. Notably, wild-type peaks are
shorter on average (114 bp versus 609 bp), and on a num-
ber of occasions multiple wild-type peaks fall within a sin-
gle vhl peak. When the number of tags was examined, the
5177 vhl peaks represented 360746 tags and the 1280
wild-type peaks represented 12158 tags.
In order to perform an unbiased identification of Hif-1α
binding sites, de novo motif analysis was carried out using
Multiple Em for Motif Elicitation (MEME) (version 4.9.0,
http://meme-suite.org/) using ±50 bp from the summits of
the top 1000 peaks from the vhl mutant data set [63]. This
identified an RCGTG motif that is also observed in human
HREs (Fig. 2) [33]. Similar analysis using the wild-type data
set did not find any motifs. The RCGTG motif was then
used to search against both the wild-type and vhl mutant
data sets. We searched for the RCGTG motif in 100 bp
surrounding the summit. This analysis identified 168
unique peaks in the wild-type data set and 4232 unique
peaks in vhl data set [64]. Notably, of the 168 wild-type
HRE peaks, 66 were found to overlap more than 50 % with
the vhl peaks. When analysed using Motif Occurrence De-
tection Suite (MOODS) (v 1.0.1, http://www.cs.helsinki.fi/
group/pssmfind/) with an e-value cut-off of 0.001 and Zv9
genome as a background, there was some degree of correl-
ation between the peak p-value and presence of the
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Fig. 1 vhl mutants shows specific enrichment for the epo-HRE. Graph showing the result of a ChIP-qPCR experiment. In vhl mutants HIF is stabilised and is
expected to bind to HREs. Strong enrichment (22-fold) for the region spanning the epo-HRE is seen in vhl mutants, whereas the wild-type HRE, and flanking
regions both up- and down-stream of the HRE are much less enriched. A control region ~2Kb distally was used for comparison. Details for the sequences
and relative positions of primers as well as the fold change calculation can be found in the Additional file 14 and the Methods section
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RCGTG motif when peaks were ordered by p-value and
binned into groups of 1000 (Fig. 3). Importantly, when the
distribution of the RCGTG motif within the surrounding
1000 base pairs of the peak was analysed, a strong prefer-
ence for the motif to be found close to the summit of the
peak was observed (Fig. 4). This is important as the
RCGTG motif is over represented in the genome, with it
occurring at greater than one in every 256 bp by chance.
When we examine the distribution of the Hif-1α binding
sites with respect to the nearest transcriptional start site
(TSS) we see that 30 % of them fall within the TSS and 6 %
fall within the promoter region but that they may also fall
at greater distances (Fig. 5). The data detailing the positions
of the ChIP peaks can be found in: Additional file 4 - unfil-
tered ChIP sequencing peaks for vhl mutants, Additional
file 5 – vhl ChIP sequencing peaks filtered for presence of
a HRE, Additional file 6 – unfiltered ChIP sequencing
peaks for wild-type, and Additional file 7 – wild-type ChIP
sequencing peaks filtered for presence of a HRE.
Validation of ChIP-seq peaks
To validate the ChIP-seq peaks in vhl, 20 highly signifi-
cant peaks containing a HRE, were selected and ChIP-
qPCR was performed using primers designed around the
region containing the HRE. As negative controls, distant
regions which did not contain a peak were selected.
qPCR was performed using input and ChIP material and
enrichment for the region of interest was determined
using a variation on the Pfaffl method as described earl-
ier. In samples from the vhl ChIP, all 20 regions showed
Fig. 2 The primary motif found in vhl mutant ChIP-peaks. The most significant 1000 peaks from the sequencing of the vhl mutant ChIP material were
analysed for the presence of sequence motifs in the 100 bp surrounding the centre of the peak using MEME. This identified a motif that closely resembles
the known HRE consensus [41]. The y-axis shows the Relative Entropy in bits, a measure of the probability that the letter will be found at that position
relative to the total information content of the stack, the x-axis shows the width of the motif in base pairs. More information can be found on the MEME
website (http://meme-suite.org/doc/examples/memechip_example_output_files/index.html?man_type=web)
Fig. 3 HREs are enriched in the most significant peaks. The peaks from our HIF ChIP-seq experiment were ranked according to p-value, a measure
of their height above the (local) background of mapped sequence tags. They were then binned into groups of 1000, the percentage of peaks
containing an HRE was then calculated, this showed that the most significant peaks show enrichment for HRE’s
Greenald et al. BMC Genomics  (2015) 16:923 Page 5 of 17
enrichment of over twenty fold regardless of which con-
trol region was used. Additional file 8 shows the fold
change values which represent peak enrichment, using
the least significant control region, approximately 1Kb
down-stream of jmjd6. In wild-type ChIP materials, a
degree of enrichment was seen for many peaks, which
indicates there may be a low level of Hif-1α binding.
This is put into context by comparing the ratio of fold
change between vhl and wild-type. In all but one case
vhl was seen to be more strongly enriched often by more
Fig. 4 The RCGTG/HRE motif is enriched in regions in close proximity to the peak summit. The position relative to the peak summit of the total number
of HRE’s in the vhl mutant data set was assessed. The X axis displays the distance from the summit in basepairs, and the y-axis the number of HREs that
fall into a given window. The majority of peaks are found with ±100 bp of the summit when the surrounding 1 kb was analysed
Fig. 5 The distribution of Hif-1α binding sites in vhl mutant zebrafish. a: Definitions of genomic regions. TSS: If peak summit is 1Kb up or down-stream
of the TSS of the closest gene (−1Kb to +1Kb). Promoter: From -5Kb upstream to upstream limit of the TSS (−1Kb). Inside: Inside the gene, including
introns and exons but excluding areas covered by the TSS. Proximal: 5 Kb Up- and down-stream of the limits of the promoter and inside region. Distal:
90Kb up- and down-stream of the proximal regions. Desert: Any region up- or down-stream of the distal regions. b: The proportion of peaks containing
HRE’s that fall within a given region for vhl mutants. c: The proportions of the genome that are described by the regions defined in a
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than 100 fold. With these findings, alongside the obser-
vation of the strong representation of HRE’s proximal to
the peak summit, we are satisfied that the peaks found
in vhl mutant ChIP-seq represent Hif-1α binding.
Comparison of microarray and ChIP-seq data
In order to investigate the extent to which Hif-1α bind-
ing influences the transcriptional profile of vhl mutant
zebrafish, we compared the gene expression changes in
vhl vs. WT and the peaks for the Hif-1α ChIP performed
using vhl mutant embryos.
As we found such a high number of Hif-1α binding
sites in vhl mutant samples (5177), we were concerned
that this could lead to a high number of false associa-
tions with genes in their vicinity. In order to minimise
this, we chose to examine region-gene associations
where the peak is within ±1Kb of the TSS. We achieved
this by mapping the region-gene associations using
Genomic Region Enrichment Analysis Tool (GREAT)
selecting for the two nearest genes, then selecting genes
within ±1Kb of the TSS [65]. This found 1722 gene as-
sociations from 1670 of the peaks that fall within ±1Kb
of the TSS. We examined the degree of overlap between
the microarray data and the genes associated with Hif-1α
peaks in their TSS. We found that of the 295 up-regulated
genes (FC ≥ 2), 73 of these were associated with Hif-1α
peaks within ±1Kb of their TSS. Whilst of the 442 down-
regulated genes, 26 were associated Hif-1α binding peaks
within ±1Kb of their TSS. In order to assess the signifi-
cance of the intersection between the differentially regu-
lated genes in the microarray and the genes associated
with Hif-1α DNA binding ±1Kb of their TSS, we per-
formed hypergeometric analysis. Our microarray contained
13691 genes with a unique gene symbol, when GREAT
was used to assess the number of genes with Hif-1α DNA
binding ±1Kb of their TSS, 1722 genes were found, with
1314 of these being included in the microarray. When the
probability that the up-regulated genes (295) associated
with ChIP-seq peaks in vhl mutants (73) occurred by
chance was assessed, hypergeometric testing gave a
probability of ≤1.5 10−14. When the probability that down-
regulated genes (442) associated with ChIP-seq peaks in
vhl mutants (26) occurred by chance was assessed, a hyper-
geometric testing gave a probability of ≤0.99. Additional
file 9 shows the genes and the peaks associated with them.
Overall, if a gene is up-regulated, the chance that it con-
tains a HRE-peak near the TSS is about four times higher
than if it is down-regulated and about 2.5 times more than
expected by chance. However, the probability of whether a
ChIP seq peak contains an HRE is not related to whether
it is associated with an up- or down- regulated gene. Intri-
guingly, non-HRE peaks show similar enrichment in TSS
regions and are found to be associated with up-regulated
genes. For instance, 39 % (367/945; non-HRE) and 34 %
(1457/4232; HRE) of the peaks were closely associated
with TSS regions.
Comparison with published HRE data in zebrafish and
human
In zebrafish HREs are known for leg1a/b, birC5a/b, peri-
od1b, epo and igfbp1a. We confirmed peaks at the pre-
dicted position for igfbp1a, epo, and peaks coinciding with
HREs E2 and E3 from period1b (but not E4). For period1b
we found a novel peak in intron1. We were unable to de-
tect the HREs described for leg1 and birC5 genes. We have
not yet checked whether there are “sub-threshold” peaks
at their predicted position in our data set.
To evaluate how well our data corresponds with mam-
malian HRE data, we did several comparisons. First we
asked whether a set of well-known HIF targets had associ-
ated peaks in our data. We collated an extensive list of
107 targets based on [66]. In 94 cases we were able to
identify a clear orthologue (or orthologue-pair, as zebrafish
have undergone a further partial genome duplication) and
in 66 of 128 orthologues (51 %) a peak could be identified
within the orthologous gene, or the 15Kb surrounding
genomic sequence. For a random set of 105 genes this was
32 (30 %), showing significant enrichment (χ2 p < 0.002;
Additional file 10).
Secondly, for 12 well-known human HIF targets with
experimentally characterised HIF-binding sites, we com-
pared the position of the known HIF-binding site to our
peaks. We estimated that in roughly 7–9 out of 12
genes, peaks were identified in comparable places near
zebrafish orthologues (Additional file 10). Often, we
identified further peaks that were not described. We also
compared our data with a human ChIP seq dataset [33].
This study identified the largest number of Hif-binding
sites until now (but it was also incomplete, as “classical”
targets like EPO, VEGF and EGLN1 were not found,
whereas they are present in our dataset). We analysed
more than 50 of their top peaks and analysed whether
peaks occurred in similar positions in our study. We only
selected peaks that fell within those genes, or <10Kb from
TSS/3′UTR. In 15/39 cases similarly positioned peaks
were noted (Additional file 10). Sequence comparison of
10 such coinciding peaks in fish and human, failed to un-
cover significant sequence homologies.
Finally, we used the GREAT website [67] to select all
peaks from Schödel et al., that fall within the TSS ± 1Kb
from a gene and identified 112 genes. Of these, 102 had
zebrafish orthologues. Using our ChIP-seq data, GREAT
identified 1722 peak associated genes from 17059 genes
with the same characteristics. When the peak associated
genes from Schödel et al., were compared with our peak
associated genes; out of 102 genes, 25 fell within the set of
1722 (Additional file 10), which represents a significant
Greenald et al. BMC Genomics  (2015) 16:923 Page 7 of 17
enrichment (p = 2.5 10−5) when hypergeometric analysis
was performed.
In the zebrafish pfkfb3 gene, an unusual pattern of peaks
was found. Pfkfb3 is an important regulator of glycolytic
flux and part of a family of 4 pfkfb genes in mammals that
probably arose through genome duplications, as primitive
chordates and Drosophila only contain a single pfkfb gene.
Surprisingly, nine peaks were identified near pfkfb3. This
gene was the only gene in the genome where we found
multiple peaks located in the middle of exons: 4 in coding
exons and one in the 3′UTR. The peaks in coding exon 8
and the 3′UTR had a (bidirectional) HIF-binding sequence
“CACGTG” near the summit. The exon 8 peak was also
found in our wild-type sample (Additional file 11). We
explored how the HIF binding site in exon 8 evolved. In
this unique situation flanking coding sequence conserva-
tion can help to follow the binding site over long evolu-
tionary distances. In human, both pfkfb3 and pfkfb4 are
regulated by hypoxia and both contain the CACGTG
sequence. Zebrafish pfkfb4a/b lack the CACGTG se-
quence, and, as predicted, do not show exonic ChIP-seq
peaks. Other pfkfb orthologues in zebrafish lack the
CACGTG sequence and also lack ChIP-seq peaks in exon
8 (despite the fact that some retain a “reverse” CACGT
consensus sequence). In human, pfkfb1 and pfkfb2 also
lack the sequence. This element has most likely arisen
during early vertebrate evolution, it can first be recog-
nised in a jawless vertebrate, Pteromyzon marinum
(www.ensembl.org), but not in more primitive chordates
or Drosophila.
Discussion
Here we describe the use of ChIP coupled to next-
generation high-throughput sequencing to identify Hif-1α
binding sites throughout the zebrafish genome in the vhl
mutant. ChIP allows unbiased genome-wide coverage of
the zebrafish genome to identify Hif-1α binding sites,
enabling development of zebrafish as an emergent model
organism for research into the hypoxic response in a
physiological context [41, 42, 46, 52, 68]. The use of the
vhl mutant, a zebrafish model for hypoxia, has allowed us
to compare Hif-1α binding sites with gene expression
changes seen in this mutant.
Microarray analysis of gene expression changes in vhl
mutants compared against wild-type controls produced
both expected and unexpected results. The up-regulated
genes included many classical hypoxia response genes
that are associated with loss of Vhl in mammalian cell
lines (Additional file 1). This reinforces the idea that the
hypoxic response is activated in the vhl mutant. Con-
trary to this, we see similar numbers of down-regulated
genes. Currently, there is little evidence in the literature
for HIF to act as transcriptional repressor. However,
pVHL is thought to have both HIF-dependent and HIF–
independent functions [69]. The latter include; extracel-
lular matrix deposition [70], cell senescence [71], apop-
tosis [72] and microtubule stabilisation and regulation of
the primary cilia [73]. It is not inconceivable that loss of
Vhl’s HIF-independent functions may lead to a signifi-
cant number of both up- and down-stream transcrip-
tional changes. Furthermore, these transcriptional
changes may be complicated by the use of a whole or-
ganism model. Vhl mutants have had activation of the
hypoxic response over a period of several days, leading
to additional transcriptional changes which would not
be identified in cell-culture models, using more acute
stimulation. Interestingly, we see that of these down-
regulated genes, 12 are predicted to be involved in ‘lipid
biosynthetic processing’ by DAVID (Additional file 3).
This finding is of interest as HIF-2 activation was
reported to affect lipid metabolism in hepatocytes caus-
ing a decrease in lipogenic gene expression and on a
physiological level, leading to hepatic steatosis in liver-
specific Hif-2α mutant mice [21]. Although the hist-
ology of the liver has not been reported in vhl mutant
zebrafish, evidence of increased lipid storage has been
detected in the pronephric tubules of vhl mutant em-
bryos [44]. The effects of hypoxia on lipid processing
have not been well studied, and strong representation of
genes related to this process in the vhl mutant, in our
view, warrants further study. This highlights an import-
ant consequence of using whole zebrafish to study the
effects of hypoxia. The presence of a variety of cells, tis-
sues and organs in a whole animal may on the one hand
complicate analysis, however, for the same reasons
novel, more tissue-specific HIF targets can be found. In
addition, targets might be found whose expression is
modulated indirectly, as a result of signalling between
tissues in the intact organism.
To locate Hif-1α binding sites we first identified the most
highly represented motif found within the peaks seen in
vhlmutants. An RCGTG (with preference for A) motif that
is identical to the consensus motif identified in human
hypoxia response genes was found using genome-wide
ChIP approaches (Fig. 2) [33, 34]. Additionally, it is highly
similar to the HRE identified from the Hif binding regions
of epo in another fish species Takifugu rubripes [35]. This
is both reassuring and unsurprising as the HIF pathway is
strongly conserved throughout the phylogeny [74].
Our experiments identified 4323 candidate HIF binding
loci and possibly up to 5177 sites, a greater number of loci
than might have been expected, as previous studies have
identified approximately 400 HIF-1α binding loci in hu-
man cells [33]. Despite this, we are confident that our 4323
sites are due to Hif-1α binding. Firstly, the majority were
not identified in WT animals where nuclear Hif-1a levels
are expected to be very low, thus they are unlikely to
pulled down due to spurious interactions of the antiserum
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and unrelated DNA binding proteins. Secondly, they con-
tain the highly conserved RCGTG in close proximity to
the peak summit (Fig. 4). We interpret this as a strong in-
dicator that these HRE-containing peaks are due to Hif-1α
binding.
It is notable that 945 of the peaks we found do not
contain RCGTG motifs in the surrounding 100 bp, the
relevance of these peaks is currently unknown. We
investigated whether these non-HRE peaks were due to
non-specific binding of the anti-Hif-1α antibody, this
was achieved by examining the overlap between these
peaks with all the peaks found in wild-type embryos
(1284). We found that, although 45 of the 945 peaks
found in vhl mutants overlapped >50 % with the wild-
type peaks (Additional file 12), the vast majority of these
peaks did not overlap. We reason that if the anti-Hif-1α
antibody is binding non-specific DNA-interacting tar-
gets, then this would lead to non-HRE containing ChIP
peaks. However, we would also predict that many of
these peaks would be shared between wild-type and vhl
samples. As we find this is not the case for the majority
of ChIP peaks, and that MEME analysis did not detect
any other motifs, we suggest that there may be other ex-
planations for the non-HRE peaks. These could represent
HIF binding to off-centre HREs or indirect binding via
other DNA binding proteins or alternatively, these peaks
may contain HREs that do not conform to the RCGTG
consensus. We were interested if there were indications
that these non-HRE peaks may represent Hif-1α binding
leading to changes in gene expression. Using GREAT, we
compared the distribution of non-HRE peaks with that of
HRE-peaks and found a very similar pattern. Although
this association does not prove the functional importance
of these non-HRE peaks, it suggests that they may have a
role in regulating transcription.
Although we do not have functional data to draw direct
links between Hif-1α DNA binding and transcriptional
activation we were interested to see if Hif-1α peaks in the
TSS correlated well with gene expression changes in vhl
mutants. In vhl mutants, we found that of the 295 up-
regulated genes, 73 had Hif-1α peaks in their TSS regions
whilst of the 442 down-regulated, 26 had Hif-1α peaks in
their TSS regions. Although we found some Hif-1α peaks
associated with down-regulation of gene expression, we
found a much larger proportion associated with transcrip-
tional activation. When we performed hypergeometric
analysis of these data sets, we found that the correlation
between up-regulated genes and Hif-1α binding peaks was
significant (p ≤ 1.5 10−14), whilst it was not for down-
regulated peaks (p = 0.99). This is broadly in agreement
with the consensus in the literature, that Hif-1α is not
thought to directly regulate transcriptional repression
[75], but functional experiments to investigate the possi-
bility direct Hif-1α mediated repression of gene expression
would be of interest. It should however also be noted that
many of the genes up-regulated in vhl microarrays did not
have HRE’s in their TSS regions. It is as yet unclear as to
why this is exactly. Importantly, our analysis of the
relationship between Hif-1α binding and gene expression
has focused on peaks that fall within the TSS, however,
many peaks are found outside the TSS and promoter
regions (Fig. 5), which is in agreement with the situation
in human [33]. Unfortunately these peaks are very difficult
to assign reliably to genes, as distance to the TSS can be
misleading to detect functional enhancers. In addition, as
HIF is a master regulator and activates other signalling
pathways (eg VEGF, Epo) and transcription factors, indir-
ect targets are undoubtedly present in the microarray.
Our study found a much higher number of significant
peaks in vhl mutant zebrafish than have previously been
found in cell culture studies where physical hypoxia or
DMOG have been used to stimulate the HIF response
[33, 34]. Indeed, we find a considerably higher number
of significant peaks containing the RCGTG motif than
we find up-regulated genes. This begs the question: why
are there so many more peaks found using the vhl
mutant zebrafish than hypoxically stimulated cells? A
number of explanations are conceivable. Firstly, the em-
bryos we used at 4dpf and have been stimulated for a
longer time than the cells used by Schödel et al., who
expose them for 16 h, this could lead to greater accumu-
lation of Hif-1α [33]. Secondly, the vhl zebrafish con-
tains a wide array of cells and tissues which may have
different Hif-1α DNA binding profiles, thus leading to a
greater number of peaks than would be found from just
one cell-type. Finally, we have used a genetic method to
stimulate the Hif pathway, which blocks the degradation
of Hif. We speculate that this leads to a glut of Hif-1α
accumulating in the nucleus, and thus promoting more
binding than would be seen by physiological activation
[76]. In order to ascertain whether individual peaks are
functional, further work is needed.
Our data can be used confirm known and identify novel
potential HIF regulated genes, including, for example,
miRNAs. Some examples of this are given in Additional
file 11. In zebrafish Hif-target genes, we can predict where
HRE are located to guide further experiments. In addition,
we see some conservation of where HRE peaks are located
when compared to human, so our data may also guide
HRE discovery in mammals. For example, we predict an
important HRE to be present in exon 8 of the human
pfkfb3 and pfkfb4 genes.
Conclusions
Here we present transcriptional analysis of the vhl mutant
with respect to Hif-1α as a known regulator of the hypoxic
response. We found that, unlike some cellular models,
which use physical hypoxia or pharmaceutical stimulation
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to inhibit the PHD’s, genetic inactivation of vhl led to both
positive and negative transcriptional changes. This may be
due to disruption of Vhl’s Hif-independent roles, or alter-
natively this may be due to studying the effects of activa-
tion of genetically induced hypoxia in a whole organism.
ChIP-seq for Hif-1α in vhl mutants found a great number
of peaks and from these the canonical HRE was identified.
We found more HRE-containing peaks than transcription-
ally activated genes, suggesting that Hif-1α binding may
not be sufficient for transcriptional activation. Some ChIP
peaks did not contain a HRE, although they do not appear
to be due to non-specific binding of the anti-Hif-1α anti-
body and some are found within the TSS regions of tran-
scriptionally active genes suggesting that they may have
some functional relevance. We hope that these data can
be used to aid further investigation into the Hif transcrip-
tional response and the development of the zebrafish as a
model for research into the hypoxic response.
Methods
Zebrafish husbandry and lines
Fish husbandry was performed at the Bateson Centre
aquaria at The University of Sheffield and conformed to
UK Home Office requirements. Breeding and experiments
were approved by the ethics committee in the University
of Sheffield and performed under project licence numbers
which were 40/3262, 40/3082 and 40/3641 issued to Dr
Freek van Eeden and under the personal license 40/9657
issued to David Greenald. Adult fishes were maintained
on a 14:10-h light/dark cycle at 28 °C with feeding of live
artemia and/or dry food twice daily.
The Tg(phd3::EGFP)i144/i144 line is a hypoxia reporter
line created by Bacterial Artificial Chromosome-mediated
transgenesis [46]. The vhlhu2117/+line was crossed into
the Tg(phd3::EGFP)i144/i144 line in order to create
vhlhu2117/+;phd3:gfpi144/i144 fish. When incrossed these
fish produce vhlhu2117/hu2117;phd3:gfpi144/i144 embryos in
Mendelian ratios [46]. Fish were pair mated and
embryos were sorted into groups of 40 and placed in
Petri dishes containing fresh E3 (5 mM NaCl, 0.17 mM
KCl, 0.33 mM CaCl2, 0.33 mM MgCl2, pH 7.2) media
containing methylene blue (Sigma-Aldrich) at 0.0001 %
and raised at 28 °C.
RNA isolation, processing and microarray hybridisation
Three batches of 30 4dpf wild-type and vhl mutant em-
bryos were snap-frozen and stored at −80 °C. Extraction
of total RNA from zebrafish embryos was performed
using the mIRVANA miRNA isolation kit (Invitrogen)
excluding the step for enrichment of miRNA. Extracted
RNA was quantified using a Nanodrop ND-1000 spec-
trophotometer. Quality of RNA was assessed using
Agilent Bioanalyser 2100 Nanochip 6000, samples with
RNA Integrity Numbers ≥ 7 were accepted.
Microarrays utilised custom designed oligonucleotide
arrays designed by Compugen and synthesised by
Sigma-Genosys [77]. Microarrays were performed on the
Agilent platform using one-colour microarray-based
gene expression analysis using Cy3-labelled targets to
measure gene expression. Using 400 ng RNA as starting
material, Cy-3 labelling, hybridisation, washing, scanning
and feature extraction were performed according to man-
ufacturer’s protocol (One-Colour Microarray-Based Gene
Expression Analysis (Quick Amp Labeling), Version 5.7,
March 2008) for 4 x 44 K microarrays. cRNA was quanti-
fied using the Nanodrop ND-1000from which yield and
labeling efficiency were calculated. The quality of cRNA
was measured using an Agilent Bioanalyser 2100 with
Nanochip 6000 to check that the majority of the cRNA
falls within 200–2000 bp and that there were no distinct
bands below 200 bp.
Scanning was performed using the GenePix 4000B
(Axon Instruments) according to manufacturer’s protocol
(One-Colour Microarray-Based Gene Expression Analysis
(Quick Amp Labelling), Version 5.7, March 2008) produ-
cing a 16-bit TIFF image upon which feature extraction
was applied using Aglient Feature Extraction software ver-
sion 10.7.3.1.
Custom oligonucleotide zebrafish arrays (Agilent)
The array chips contain 41,091 probes, which corresponded
to 28864 unique entities with a Unigene ID when the cus-
tom annotation software (GIS Unigene and Gene Ontology
Annotation tool, http://123.136.65.67) was employed. Not-
ably, these Unigene ID’s corresponded to 110649 fully an-
notated genes, i.e. those which have a Gene Symbol and
Gene description, and 14321 of which corresponded to
transcribed loci/CDNA clones and partially annotated
genes.
Microarray data analysis
Quality of microarray data was assessed using the ‘Quality
Control on Samples’ function using Genespringf 12.6 GX
(Agilent). Limma Version 3.24.10 (Biocondutor) was used
to load three samples from raw text files for both wild-type
and vhl mutants. Background correction was applied using
the “normexp” function and normalisation was performed
using normalise between arrays “quantile” function. To
average replicate spots, the “avereps” function was applied.
The linear model was applied using “lmfit” and a contrast
matrix was applied using eBayes (fit2). From these nor-
malised entity lists, a significance cut off of p ≤ 0.01 and
fold change cut off of ≥ 2 were applied.
To annotate the Probe ID’s, probenames are exported
to the GIS Unigene & Gene Ontology Annotation Tool
(http://123.136.65.67/) and the corresponding Genbank
Accession and Unigene ID’s were found for Danio rerio
(DR Build #126_66).
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Microarray validation
The degree of concordance between the fold change values
from the microarray analysis and the qPCR was calculated
using Spearman’s coefficient [61]. cDNA was created from
the same pool of RNA used for the microarray experiments
by reverse transcription using Superscript III First-Strand
Synthesis System (Invitrogen) using 1 μg RNA and
OligiodT. qPCR for Microarray Validation carried out
using the Applied Biosystems Sequence Detection System
(SDS) Software v2.4.1 in conjunction with 7900HT Fast
Real-Time qPCR System.
qPCR was carried out in a 384 well plate format, using
the Applied Biosystems Sequence Detection System
(SDS) Software v2.4.1 in conjunction with 7900HT Fast
Real-Time qPCR System. Cycling conditions of 50 °C - 2
min, 95 °C - 10 min, [95 °C – 15 s, 60 °C - 1 min] × 40
cycles were used. Cycle threshold (Ct) values were calcu-
lated automatically using the software, with ROX used
as the passive reference.
cDNA concentration curves were created using 4dpf
WT RNA, starting at 500, 150, 50, 15, 5, 1.5, 0.5 and finally
0 ng/μl. Primers were tested in triplicate, and efficiencies
were calculated from averaged Ct values plotted against
the log10 of concentration of cDNA and the gradient (m)
line of best fit was taken. Efficiency was calculated from
the average of 3 technical replicates for each primer.
Efficiency ¼ 10ð1=mÞ
FC ¼ ðEtardCttarÞ=ðECN dCtCNÞ
This was performed for vhl vs wild-type.
The suitability of the reference gene was then assessed
by performing Kruskal-Wallis One-way ANOVA with
Dunn’s Multiple testing (P < 0.05) for each of the above
comparisons. Wnt5a and 18 s passed for all comparisons
and were subsequently used for Microarray Validation.
Additional file 13 contains the details of the primers
used for microarray validation.
ChIP-sequencing: sample preparation
Vhlhu2117/+;phd3:gfpi144/+ fish were incrossed and
Vhlhu2117hu2117+;phd3:gfpi144/+embryos were sorted from
non-fluorescent siblings prior to de-yolking. Vhl mutants
were sorted and deyolked by trituration in 4 °C deyolking
buffer (55nM NaCl, 1.8 mM KCl, 1.25 mM NAHCO3, 1x
Complete protease inhibitor (Roche) ) followed by
shaking on a bench-top vortex at 1000 rpm for 5 min.
Embryos were pelleted by centrifugation at 1000 rpm
for 30 s at 4 °C and supernatant discarded. Embryos
were washed using wash buffer (100 mM NaCl, 3.5 mM
KCl, 2.7 mM CaCl2, 10 mM Tris–HCl pH 8.5, 1x
Complete protease inhibitor (Roche)) with 2 min shak-
ing at 1000 rpm on a bench-top vortex. Embryos were
washed in 4 °C 1X PBS and pelleted by centrifugation
at 1800 rpm. Embryos were then macerated and resus-
pended in 10 ml 1.1 % formaldehyde in 1 X PBS (5 mM
Hepes-KOH pH 7.5, 10 mM NaCl, 100 μM EDTA, 50
μM EGTA, 1.1 % formaldehyde, 1x Complete protease
inhibitor (Roche)). The embryos were incubated for 10
min at room temperature, gently rocking. Formalde-
hyde was quenched by addition of 1 ml of 2.5 M glycine
with 1x Complete protease inhibitor (Roche) and incuba-
tion for 5 min with gentle rocking. Samples were then
spun at 3500 rpm at 4 °C for 5 min in an Eppendorf 5810
R Centrifuge before snap freezing in liquid nitrogen. Once
2400 embryos were collected for wild-type and for vhl
mutants, ChIP could proceed.
ChIP-sequencing: cell sonication
Macerated embryos were lysed in 3 ml Cell Lysis Buffer
(10 mM Tris–HCl pH 7.5, 10 mM NaCl, 0.5 % Igepal
CA-630, 1 x Complete protease inhibitor (Roche) and
incubated on ice for 15 min. Samples were centrifuged
at 3500 rpm and the supernatant discarded. The pellet
was resuspended in 1.5 ml Nuclei Lysis Buffer (50 mM
Tris–HCl pH 7.5, 10 mM EDTA, 1 % SDS and 1X
Complete protease inhibitor (Roche)) and incubated
over ice for 10 min. Two volumes of Immunoprecipita-
tion Dilution Buffer (16.7 mM Tris–HCl pH 7.5, 167
mM NaCl, 1.2 mM EDTA, 0.01 % SDS, 1x Complete
protease inhibitor (Roche)) were added and the samples
were sonicated at 25 cycles at 40 % amplitude, 18 s pulse
and 59.9 s rest using a Branson Sonicator 450D. After
sonication, 300 μl 10 % Triton was added to 4 ml chro-
matin followed by centrifuged at 13,300 rpm for 10 min
at 4 °C and the supernatant was saved. 150 μl of the cell
lysate was saved at −20 °C to create input control.
ChIP-sequencing: pre-block and binding of Hif-1α
antibody to magnetic beads
100 μl Dynabeads A magnetic beads (Life Technologies)
were washed with 1 ml PBS with 1 X Bovine Serum
Albumin. Beads were collected by centrifugation at
3000 rpm for 3 min at 4 °C in 1.5 ml tubes. The beads
were washed 2 x in 1 ml PBS-BSA and collected with a
magnet. 10 μg of Hif-1α antibody in 250 μl PBS/BSA
was added to the beads and incubated overnight at 4 °C.
The beads were then washed 3 x in 1 ml PBS-BSA and
resuspended in 100 μl PBS/BSA.
ChIP-sequencing: chromatin immunoprecipitation
The pre-blocked Dynabeads were added to the sonicated
chromatin and incubated overnight at 4 °C.
ChIP-sequencing: wash, elution and cross-link reversal
Beads were precipitated using a magnetic stand and
washed x8 in 4 °C RIPA wash buffer (50 mM Hepes-
KOH pH 7.6, 1 mM EDTA, 500 mM LiCl, 0.7 % Na-
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Deoxycholate, 1 % NP-40), x1 in TBS and centrifuged
for 3 min at 3000 rpm after which all TBS was aspi-
rated. 250 μl of Elution Buffer (50 mM Tris–HCl pH
8.0, 10 mM EDTA, 1 % SDS) was added prior to incu-
bation at 65 °C for 15 min in a water bath with brief
vortexing every 2 min. The beads were centrifuged at
13,300 rpm for 1 min and the supernatant saved as this
contains the ChIP material.
The input sample saved earlier was thawed and 3
volumes of Elution Buffer was added. Both ChIP and
Input samples were incubated at 68 °C for 3 h shaking at
1300 rpm to reverse cross-linking.
ChIP-sequencing: digestion of cellular protein and RNA
Three times volume TE was added to each sample, RNa-
seA (0.2 μg/ml final concentration, Qiagen) was added and
samples were incubated at 37 °C for 30 min to degrade
RNA. To degrade protein, proteinase K (Sigma-Aldrich)
(0.2 μg/ml final concentration) was added and incubated at
55 °C for 1 h.
To isolate DNA, 400 μl phenol:choloform:isoamylalcohol
(Ambion) was added to each sample and phases separated
using 2 ml Heavy Phaselock (Qiagen) according to manu-
facturer’s instructions. The aqueous layer was recovered
and NaCl (200 mM final concentration) and 30 μg glyco-
gen from Mytilus edulis (Sigma-Aldrich) was added. 800 μl
ethanol was added and the samples were incubated for 1 h
at −80 °C prior to centrifugation at 13,300 rpm at 4 °C for
10 min. Supernatant was removed, and the pellet washed
with 75 % Ethanol, before being air-dried and resuspended
in 20ul 10 mM Tris–HCl pH 8.5. DNA concentration was
measured using the QuBit 2.0 system (Invitrogen).
ChIP-sequencing: ChIP-qPCR
Primers were designed around the EPO-HRE, see
Additional file 14 for details.
Primers were validated using a DNA concentration
curve of 300, 100, 30, 10, 3, 1 and 0 ng genomic DNA
from zebrafish. qPCR was performed using the 7500
Applied Biosystems qPCR Real-time PCR system using
the cycling conditions: 50 °C - 2 min, 95 °C - 10 min,
[95 °C – 15 s, 60 °C - 1 min] x 40 cycles, with the
additional pre-programmed dissociation stage. Primers
were tested in triplicate and efficiencies were calculated
from averaged Ct values plotted against the log10 of
concentration of DNA and the gradient (m) line of best
fit was taken. Efficiency was calculated from the average
of 3 technical replicates for each primer.
Efficiency ¼ 10ð1=mÞ
qPCR was performed using 4 samples for each primer
set, wild-type input and ChIP and vhl mutant and ChIP.
For each qPCR experiment only 0.01 ng of DNA was
used. Fold change was calculated using a variation on
the Pfaffl ratio [58]. The change in Ct value between
Input and ChIP for both the target region (dCttar) and
the reference region (dCtref ) were calculated thus:
dCt ¼ CtInputCtChiP
FC ¼ ðEtardCttarÞ=ðECNdCtCNÞ
Additional file 15 contains details of the primers used
to validate the sequencing.
ChIP-sequencing: library preparation
Using 5 ng of ChIP material and 10 ng of input material
for both wild-type and vhl mutants library preparation
was performed using the Illumina Truseq ChIP Sample
Preparation Kit set A (REF: 15034288) in accordance
with manufacturer’s instructions using the adapters 2, 7
for input in duplicate and 19 for the ChIP samples to
allow multiplexing. Following library preparation, the
amplified adapter bound materials were tested for size
and approximate quantification using High Sensitivity
DNA assay using the 2100 Agilent Bioanalyser according
to manufacturer’s instructions. On the basis of the
approximate quantification, precise quantification was
performed using qPCR as recommended by the protocol
following internal guidelines for submission of sequen-
cing samples at the Genome Institute of Singapore.
Samples of 8pM, 4pM, 2pM and 1pM were amplified
using appropriate adapter primers at 0.1 μM and Roche
SYBR Green I Master in a Roche Lightcycler 480.
Cycling conditions of pre-incubation at 95 °C for 5 min
followed by 30 cycles of 95 °C for 10s sec, 60 °C for 1
min, and 72 °C for 30 s, then a melting curve 95 °C 5 s,
65 °C for 1 min and 97 °C for 10 s decreasing 5 °C each
increment before cooling to 40 °C. Quantification is
achieved by exporting crossing point values and plot-
ting them against log concentration and performing
linear regression to calculate the line of best fit to be
used in y = mx + c where and using this to calculate the
concentration. 15 μl of 5nM between 200–300 bp is
submitted for sequencing.
ChIP-sequencing: sequencing
Sequencing was carried out a Genome Institute of
Singapore using the Illumina Genome Analyser II
(Illunima, USA) performing a single read with 3 sam-
ples per lane to allow multiplexing. Output files were ana-
lysed by Dr. Justin Jeyakani at GIS. Sequencing runs for
WT input material produced 34,915,101 unfiltered reads,
32,602,307 which passed filtering and 19,400,899 reads
which mapped uniquely using CASAVA (v 1.8.2, Illumina).
For the WT ChIP Material, there were 31,424,233 total
reads, 30331510 of which passed filtering and 16,780,814
reads which mapped to uniquely. For the VHL sequencing,
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input produced 24,823,207 total reads, 23,325,383 of which
passed filtering, and 13,834,669 which mapped uniquely.
The VHL ChIP material produced 65,797,779 total reads,
63,035,293 which passed filtering and 33,429,235 which
mapped uniquely. Only reads which mapped uniquely were
used for peak calling. All reads were 35 bp in length.
Peak calling was performed comparing ChIP material to
input using MACS (version 1.4.2 20120305), the binding
regions were ranked based on the enrichment of sequen-
cing tags by comparing each ChIP library to control [78].
A threshold of p-value > 1 × 10−5 was applied, this gave
rise to 5177 peaks in vhl ChIP and in wild-type ChIP ma-
terial versus wild-type input 1280 peaks were called.
Alignment was carried out using CASAVA (v 1.8.2, Illu-
mina) with danRer7-Zv9 as the build.
De novo motif analysis was carried out using MEME
(version 4.9.0, http://meme-suite.org ) using ±50 bp from
the summits of the top 1000 peaks [63]. This identified an
RCGTG motif (Fig. 2). This motif was then used to filter
the peaks for the presence of the motif using MOODS
(v 1.0.1, http://www.cs.helsinki.fi/group/pssmfind/) with
an e-value cut-off of 0.001 and Zv9 genome as a back-
ground, this identified 2736 peaks in vhl ChIP samples
[64]. However, as this omitted most experimentally
confirmed fish HREs, we chose to filter peaks for the
presence of a simple RCGTG sequence. In wild-type
samples, MEME was not able to find any robust motifs.
These wild-type peaks were then scanned for the motif
found in the vhl ChIP peaks using MOODS which
found 50 sites [64], whereas simple RCGTG detection
resulted in 168 sites. Peaks were confirmed on the basis
of tag distribution.
To show percentage of peaks that contain a HRE motif
within 100 bp of the peak, the peaks were ranked on the
basis of the MOODS p-value and then binned into
groups of 1000 i.e. top 1 K, 1-2 K, 2-3 K, 4 K and above
(Fig. 3). The percent of peaks that contain a HRE was
then calculated for each bin. Similarly, scanning for
motif enrichment in the 1Kb region surrounding the
peaks to show the proximity of the motifs to the peak.
Techniques employed to perform these analyses can be
found in [79–81] (Fig. 4).
To assess the genomic regions vhl mutant ChIP peaks
fell in, distance to TSS was assessed using Genomic Re-
gion Enrichment Annotations Tool (GREAT) version 2.02,
using the singles nearest gene rule [65]. Regions were then
assigned according to the diagram in Fig. 5a. In order to
calculate the amount of the zebrafish genome that falls
within these categories, a custom script was created, which
is available at https://github.com/iansealy/bio-misc/blob/
master/classify_genome_bases.pl.
To identify the genes associated with peaks Genomic
Region Enrichment Annotations Tool (GREAT) version
2.02 was used [65]. The Wellcome Trust Zv9 (danRer7,
Jul 2010) assembly was used with the two nearest genes
being used as the association rule, only peaks found
with the TSS region (±1 kb from TSS) were used.
Gene ontology analysis
Gene Ontology Analysis was performed using DAVID
Bioinformatics resource 6.7 (http://david.abcc.ncifcrf.gov/
home.jsp). Unigene ID lists for up- and down-regulated
genes were uploaded separately, using Aglient Zebrafish
background and ‘GO TERM BP FAT’ was used to assess
functional relevance of gene expression changes [56, 57].
Comparisons with published human data
A HIF-response gene list was collated based on [66]
(Additional file 10). The peak position data from [33]
were converted from NCBI36/hg18 to NCBI37/hg19
using http://genome.ucsc.edu/cgi-bin/hgLiftOver and
the resulting bed file was analysed using GREAT and the
UCSC (http://genome-euro.ucsc.edu) browser. Compari-
sons were done using our 5177 peak-set. We extracted
lists of genes associated with a peak at ±1Kb of the TSS
using GREAT for both our and the Schödel dataset, to
determine overlap.
ANOVA
For data analysed using ANOVA, normality of the data
was assessed using D’Agostino and Pearson omnibus nor-
mality test. If data passed at α = 0.05 then One-Way
ANOVA was performed, if not or the n number was too
small a Kruskal-Wallis test was performed. For One-Way
ANOVA a P value of p < 0.05 was the measure of signifi-
cance. For Bonferroni multiple comparison tests used to
compare pairs of groups a p < 0.05 as taken as significant.
If data did not pass D’Agostino Pearson, Kruskal-Wallis
ANOVA was performed with p < 0.05 taken as significant,
Dunn’s multiple comparison test p < 0.05 was used to cal-
culate significance between columns. The descriptive sta-
tistics tool was used to calculate the mean and standard
error of the mean which is shown for bar charts.
Hypergeometric analysis
Hypergeoemtric analysis was performed using the Gene-
prof Hypergeometric analysis calculator (https://www.-
geneprof.org/GeneProf/tools/hypergeometric.jsp). For the
intersection between the ChIP-seq and microarray data,
for “Population size”, we used the total number of genes
in the microarray with a gene symbol, for “Number of
successes in the population” we used the number of genes
associated with a ChIP peak within ±1Kb of their TSS in
vhl mutants according to GREAT using the two nearest
genes association rule and then filtering for presence in
the microarray. The “Sample size” is the number of
genes either up- or down-regulated in the microarray
(FC ≥ 2, p ≤ 0.01), and “Number of successes in the
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population” is the number of genes either up- or down-
regulated in the microarray associated with a ChIP-seq
peak ±1kB to their TSS’s in vhl mutants.
For the intersection between the Schodel et al., and
our ChIP-seq data, for “Population size”, we used the
total number of genes found in GREAT. For “Number of
successes in the population” we used the total number
of ChIP-associated peaks from our data found in
GREAT (two closest genes, ±1Kb TSS), The “Sample
size” is the number of zebrafish orthologues to the
ChIP-associated peaks found in Schodel et al.,. Finally,
the “Number of successes in the population” is the num-
ber is the number of our ChIP-associated genes that
have an orthologue in the Schodel et al., data set.
Supporting data
The data sets supporting the results of this article
are included within the article and its additional
files. The microarray data and ChIP-seq data have
been submitted to NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) under the super
series GSE70886. The ChIP-seq data can be found
under GSE70727 and the microarray data can be
found under GSE70885.
Additional files
Additional file 1: Gene Expression Changes in vhl mutant zebrafish.
The list of fully-annotated genes which were differentially regulated with
a fold change ≥ 2 in vhl mutants versus wild-type at 4dpf. Contains; Probe
ID, Fold Change, Log Fold Change, Unigene Description, Unigene ID and
Gene Symbol. (XLSX 65 kb)
Additional file 2: The unfiltered list of differentially regulated
genes for vhl vs wild-type. The unfiltered list of genes which were
differentially regulated with a fold change ≥ 2 in vhl mutants versus
wild-type at 4dpf. Contains; Probe ID, Log 2 Fold Change, AveExpr:
Average Expression across all arrays and Channels, t: moderated t statistic,
p-value, add.j.p-value: p-value adjusted for multiple testing, B: B statistic, the
log of the odds that the probe is differentially expressed, Unigene
Description, Unigene ID and Gene Symbol. (XLSX 6344 kb)
Additional file 3: The complete list of gene ontology terms found
by DAVID. Using data found in Additional file 2, DAVID was used to assign
gene ontology to genes using the Agilent zebrafish background and Unigene
ID as identifier. Number of genes associate with each term, p-value and
Benjamini correction are shown. (XLSX 12 kb)
Additional file 4: Unfiltered ChIP sequencing peaks for vhl mutants.
(BED 116 kb)
Additional file 5: vhl ChIP sequencing peaks filtered for presence of
a HRE. Filtering performed using MACS. (BED 70 kb)
Additional file 6: Unfiltered ChIP sequencing peaks for wild-type.
(BED 56 kb)
Additional file 7: Wild-type ChIP sequencing peaks filtered for
presence of a HRE. Filtering performed using MACS. (BED 2 kb)
Additional file 8: Validation of ChIP-seq peaks by ChIP-qPCR. Table
showing the ChIP-qPCR fold changes for both wild-type and vhl mutant
ChIP samples and the ratio of vhl/wt. (XLSX 10 kb)
Additional file 9: A table of differentially regulated genes containing
a ChIP peaks in their TSS. A table showing the position of ChIP peaks
relative the differentially expressed genes from the vhl Vs WT microarray
data found using GREAT version 2.02. Fold change, Unigene ID and
presence of a HRE are indicated. (XLSX 18 kb)
Additional file 10: Comparison of zebrafish and Human data on HIF
target genes. Sheet 1: collated list of HIF targets based on [65] with fish
orthologues and peak positions. A similar analysis of a random sample of
genes is also given, Sheet 2: Analysis of a experimentally verified peaks in
well-known targets. Sheet 3: Analysis of overlap of top ChIP-seq peaks
from [34], Sheet 4: Genes from Schödel with peaks close to TSS, stating
overlap with zebrafish orthologues with peaks close to TSS. (XLSX 39 kb)
Additional file 11: Examples of Hif-1α binding in proximity to
hypoxia response genes. In all panels the red vertical bar shows the
region of the chromosome that is enlarged in the window below. The
introns and exons of known genes in the enlarged region are annotated
in dark blue, the small chevrons on the genes show the orientation of
transcription. The window shows mapped significant peaks for WT and VHL
mutants. Peaks appear as black vertical bars. ‘VHL all peaks’ refers to all the
peaks found using MACS in the vhl mutant samples, ‘VHL HRE only’ refers to
the peaks found in vhl mutants containing the RCGTG motif in the
surrounding 100 bp and thus show a subset of the black vertical bars of
“VHL all peaks”, ‘WT all peaks’ refers to all the peaks found in wild-type
samples using MACS, and ‘WT HRE only’ refers to the peaks found in the
wild-type sample containing RCGTG motif in the surrounding 100 bp.
A: A HRE-containing peak −57 bp upstream of Prolyl 4-hydroxylase α1b
(p4ha1b), a known hypoxia response gene involved in extracellular matrix
remodelling which is found to be up-regulated in the vhl mutant by FC 34.0
in the microarray [55]. Given that this peak is highly significant, and in the
close vicinity to the TSS of a highly expressed gene, it may represent a
functional HRE for this gene. B: Screenshot showing a number of Hif-1α
binding sites in both vhl mutant and wild-type samples surrounding egln3.
Egln3 (phd3) is a gene which is seen to be strongly activated in response
to hypoxia in zebrafish [49], and is up-regulated with a FC of 151 in our
microarrays. In vhl mutants there is are two strong HRE-containing peak
residing within intron 1. Additionally, there are a number of peaks upstream
of the gene. Interestingly, there are a number of peaks found in the
wild-type sample, suggesting that there is Hif-1α binding, and possible
transcription in normoxic environments. Furthermore, these peaks are not
at the same sites as found in vhl mutants, suggesting that control of egln3
expression under normoxic environments may be influenced by more
factors that Hif-1α binding alone. It would be interesting to discover if these
HRE-containing peaks in vhl mutants control egln3 expression, and to what
extent the other peaks and “wild-type peaks” contribute to this. We suspect
high Hif-1α binding as there is an extremely high fold change found in the
microarray and the high fold enrichment of one of the HREcontaining
ChIP peaks (28.6). C: Screenshot showing Hif-1α binding in vhl mutants
surrounding the gene tiparp. The data presented here may also be useful
for investigating lesser or previously unknown Hifresponsive genes. For
instance, TCDD-inducible poly (ADP-ribose) polymerase (tiparp), is a gene
not previously associated with the Hif response but seen to be up-regulated
in the microarray by FC 3.49 which has multiple Hif-1α peaks in its vicinity,
some containing HREs. TIPARP was not recognised as being associated with
the hypoxic response by gene ontology software such as DAVID or manual
literature searches. Interestingly for tiparp a xenopbiotic response element
has been defined in mouse in the first half of intron 1 [82]. One of the two
HRE containing HIF peaks in zebrafish associated with tiparp also maps to
the first half of intron 1. As HRE and XRE consensus sequence are
essentially identical, this might in fact represent the same enhancer
responding to two different inputs. D: Screenshot showing a Hif-1α
binding site found in vhl mutants in the vicinity of mir22a-1 Despite
not being included in the microarray analysis, there is evidence of
Hif-1α binding in close proximity to three microRNAs involved in the
regulation of the hypoxic response. Hif-1a binds in close proximity to
mir22a-1, a microRNA that suppresses HIF-1α regulated transcription in
human colon cancer cells [83]. We also find sites close to mir210 and
mir-132/212 which may be involved in the hypoxic response. E: Screenshot
showing Chip-seq peaks near pfkfb3, which is unique in the genome, as it
has several exonic peaks. It also shows several peaks in the surrounding
genomic DNA. (PDF 1480 kb)
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Additional file 12: The overlap between non-HRE ChIP peaks in vhl
mutant and wild-type samples. Filtering performed manually using the
RCGTG motif. (XLSX 9 kb)
Additional file 13: Details of primers used to validate microarray.
(XLSX 12 kb)
Additional file 14: Details of primers used in ChIP-qPCR for the
epo-HRE. (XLSX 22 kb)
Additional file 15: Details of primers used in ChIP-seq validation.
(XLSX 10 kb)
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